BioMarin Pharmaceutical Inc (BMRN) Stock Price, Quote, News & History

BMRNNASDAQ
$59.74
-0.005-0.01%
Last update: Jul 9, 3:09 PM
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
874.25M
Investing Cash Flow (TTM)
339.52M
Financing Cash Flow (TTM)
809.55M
Free Cash Flow (TTM)
759.12M
Capital Expenditure (TTM)
-115.13M
Net Change in Cash (TTM)
2.02B

Analyst Trends and Forecast

1
Jan
6
1
Feb
3
1
Mar
7
3
May
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$10.77B
PE Ratio (TTM)
42.99
PE Ratio (FWD)
12.00
PEG Ratio (TTM)
0.73
PS Ratio (TTM)
3.64
PB Ratio (TTM)
1.86
Earnings Yield % (TTM)
2.33%
Earnings Yield % (FWD)
8.33%
EV / EBITDA (TTM)
22.31
Price / EBITDA (TTM)
24.48
Price / Free Cash Flow (TTM)
15.56
Book Value / Share
$32.14

Company Debt

Total Debt
$1.43B
LT Debt
$1.43B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$2.22B
Debt to Equity
0.23
Issuance of Debt (TTM)
$850.00M
Repayment of Debt (TTM)
-

Key Statistics

Open
$59.15
Close
-
Volume / Avg.
410.12K / 2.05M
Day Range
$58.45 - $60.51
52 Wk Range
49.26 - 66.28
Market Cap
$11.55B
P/E Ratio
42.99
Dividend Yield
-
Exchange
NASDAQ
RSI
63
Short Interest
6.49%
Days to Cover
6.06

About

Sector
Health Care
Industry
Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioMarin Pharmaceutical (BMRN) stock?

A

You can purchase shares of BioMarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioMarin Pharmaceutical (BMRN) competitors?

A

There are no as such competitors for BioMarin Pharmaceutical.

Q

What is the forecast, or price target, for BioMarin Pharmaceutical (BMRN) stock?

A

BioMarin Pharmaceutical has a consensus price target of $89.00.

Q

What is the current price for BioMarin Pharmaceutical (BMRN)?

A

The stock price for BioMarin Pharmaceutical (NASDAQ: BMRN) is $59.745 last updated July 9, 2026 at 3:09 PM EDT.

Q

Does BioMarin Pharmaceutical (BMRN) pay a dividend?

A

There are no upcoming dividends for BioMarin Pharmaceutical.

Q

When is BioMarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?

A

BioMarin Pharmaceutical does not have any upcoming earnings scheduled.

Q

Is BioMarin Pharmaceutical (BMRN) going to split?

A

There is no upcoming split for BioMarin Pharmaceutical.

Q

What sector and industry does BioMarin Pharmaceutical (BMRN) operate in?

A

BioMarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.